logo
The Steering Committee
Alastair Carruthers, MD, FRCP(C)
Site Disclaimer
eHealthcare Leadership Awards 2007 Winner
You need to upgrade your Flash Player
You need to upgrade your Flash Player to view this content.

What's New

• Environmental effects on skin aging, potential adverse events of onabotulinumtoxinA
Our newest slides explore the effects of environmental factors, including skin cancer history and smoking, on skin aging. We also explore a study of the safety and tolerability of onabotulinumtoxinA for facial lines.

• FDA Gives Update on Botulinum Toxin Safety Warnings; Established Names of Drugs Changed
The FDA announced an update to a previous safety alert on four botulinum toxin drug products, noting that all of them now have boxed warnings on their labels and have developed Medication Guides for patients, as directed by the agency in April 2009. More here.

• FDA Requires Boxed Warning for Botulinum Toxin Products
The FDA has notified the manufacturers of licensed botulinum toxin products of the need to strengthen warnings in labeling and add a boxed warning regarding the risk of adverse events when the effects of the toxin spread beyond the site where it was injected. The FDA also urges manufacturers to develop and implement a Risk Evaluation and Mitigation Strategy (REMS) to ensure that product benefits outweigh risk.

• FDA Warning Letter Sent for Bimatoprost Ophthalmic Solution (Latisse™)
The FDA issued a warning letter to Allergan, Inc., manufacture of the eyelash enhancer, bimatoprost ophthalmic solution (Latisse™), for minimizing risks associated with the product's use. More here.

Slides of the Month

 

In The News

Hospital For Special Surgery Is Once Again The Only New York Hospital With Surgical Site Infection Rate Significantly Lower Than State Average
Sep 02, 2010 -- For the second year in a row, Hospital for Special Surgery is the only hospital in New York State with an infection rate that is significantly lower than the state average for hip replacement or revision surgeries, according to the 2009 report on hospital infection rates released today by the State Department of Health...
DNA From National Psoriasis Victor Henschel BioBank Released For Study
Sep 02, 2010 -- Millions of Americans struggling with psoriasis and psoriatic arthritis are one step closer to a cure with the first-ever release of National Psoriasis Victor Henschel BioBank DNA samples for use in psoriasis research. The samples will allow scientists to uncover the unknowns about the genetics of psoriatic disease and its causes. James T. Elder, M.D., Ph.D...
Oral Supplements Enhance Effectiveness Of Botox Injections
Sep 02, 2010 -- Taking a dietary supplement of organic zinc and the enzyme phytase four days before receiving botulinum toxin injections made the toxin more effective in 93 percent of patients tested in a recent study at The Methodist Hospital in Houston. Dr...
Bed Bugs On The Rise
Sep 01, 2010 -- Bed bugs appear to be on the rise around the world, as more and more experts and professionals in pest control report huge rises in prevalence, even so far as to suggest we are on the verge of a bed bug pandemic...
Copyright 2007 Medical News Today
Login
Username:
Password:
Register
Forgot Password?
Ask the Expert
Have a question for one of our experts?
Submit it here

View all Questions

Participate in our
Online polls
How is bimatoprost ophthalmic solution (Latisse) integrated into treatment regimens in your practice?



Upcoming Events